Explore the key benefits of attending the 2024 DIA Middle East & North Africa (MENA) Conference with Sara Torgal, Senior Manager, Scientific Programmes, DIA. In November, join health authorities, industry leaders, and stakeholders from across the region to: ◾ Collaborate on shaping the future of regulatory landscapes. ◾ Connect with over 300 professionals from a diverse range of countries. ◾ Learn innovative strategies for advancing the development of medicinal products. The early bird registration ends on 1 October. Secure your place today: https://bit.ly/3X4ghrA. #DIAMENA2024 #Collaboration #LifeSciences #RegulatoryAffairs
DIA
制药业
Washington,DC 37,454 位关注者
Driving collaboration in drug, device, and diagnostics development in pursuit of a healthier world
关于我们
DIA is the leading global life science membership association driving collaboration in drug, device, and diagnostics development in pursuit of a healthier world. Founded in 1964 with headquarters in Washington, D.C., and offices in Europe and Asia, DIA provides unparalleled networking opportunities, educational resources, scientific research publications, and professional development programs to members in more than 80 countries.
- 所属行业
- 制药业
- 规模
- 51-200 人
- 总部
- Washington,DC
- 类型
- 非营利机构
- 创立
- 1964
- 领域
- Professional Association、Pharmaceuticals、Medical Devices、Biotechnology、Education Provider、Government、Clinical Trials、Education、Training、eLearning、Translational Medicine、Patient Engagement、Value and Access、healthcare、regulatory affairs、Pharmaco Vigilance、personaldevelopment、careers、women in science和medicine
地点
DIA员工
-
Eli Weinberg, PhD
Developing and delivering innovations in medicine
-
Joe Dustin
VP, Product Strategy | BioFourmis | eClinical Tech Executive | Advisor | AI | eCOA | DHTs | Decentralized Trials | Clinical Operations
-
Timothy Hess
Global Head of Business & Digital Technology at DIA
-
Nimita Limaye
Research VP, Life Sciences R&D Strategy and Technology, at IDC
动态
-
DIA转发了
DIA Global Forum Editor-in-Chief; Fellow of DIA; Howard University College of Pharmacy (HUCOP) Board of Visitors; Career Coach and Mentor; DEI Advocate and Ally
The September issue of DIA Global Forum is now online and includes a Special Section on the Certificate of Pharmaceutical Product (CPP) curated by our Regional Editor Cammilla Horta Gomes.
-
Join us from 4 to 7 November for the Paediatric Investigation Plans (PIPs) course! Get expert insights on PIPs, the EU Paediatric Regulation, and more. The early bird rate ends in two days — don’t miss out: https://bit.ly/4bzQSKd. Mette Due Theilade Thomsen Roberto De Lisa #PIP24 #PIP #PDCO #PaediatricInvestigationPlans
On 4-7 November, join us at the Paediatric Investigation Plans course. This training is a great opportunity to get a full introduction to the Paediatric Investigation Plans (PIPs) as well as the EU Paediatric Regulation. Curious about what you will learn? Hosted by leading experts from the EMA and consultancy, this course will cover: ✅ Definitions, Regulation, Guidelines ✅ PIP Lifecycle: Preparation, submission, modifications ✅ Global Paediatric Plan ✅ PIP Opinion ✅ Special issues: Pharmaceutical forms and formulations, non-clinical studies, clinical studies Register by 9 September to benefit from the early bird rate: https://bit.ly/4bzQSKd. Roberto De Lisa Mette Due Theilade Thomsen #PIP24 #PIP #PDCO #PaediatricInvestigationPlans
-
-
The DIA Global QPPV Forum is the premier forum designed specifically for QPPVs by QPPVs. It offers a unique opportunity to exchange knowledge, address key challenges, and network with peers from across the field. This year’s forum will focus on critical issues including global QPPV challenges, AI and digitalisation, regulatory harmonisation, and the evolving role of QPPVs. Attendees will gain insights from leading experts and engage in valuable discussions that will shape the future of pharmacovigilance. Follow our event for the latest updates and register by 11 September to benefit from the early bird rate. #QPPV #Pharmacovigilance #DrugSafety #Abstracts #QPPVTalks
此处无法显示此内容
在领英 APP 中访问此内容等
-
Don't forget to mark your calendar! This upcoming webinar is complimentary and a fantastic way to stay at the forefront of real-world topics. Raising the Bar on Real-World Data Quality: Ensuring Regulatory-Grade EHR Data In Collaboration with: Truveta September 18 | 1:00-1:45PM ET | Register Here: https://lnkd.in/ejcJks6Y Want more real-world collaboration? Check out our upcoming Real-World Evidence conference in Philadelphia, PA this fall! ➡️ https://lnkd.in/egNfP_gD
-
-
Our collaboration with Regulatory Affairs Professionals Society (RAPS) was such a great event earlier year, so we're hosting another one! This December at the 2024 Regulatory Policy Forum, get ready for a highly-interactive summit where we'll explore the new EU pharmaceutical legislation and how it will shape the future of the pharmaceutical arena — including research, development and manufacturing — in Europe for decades to come. Register before 18 October to save on this anticipated event: https://bit.ly/3YMFisn.
-
🌟 Now Available: September Issue of Therapeutic Innovation & Regulatory Science (TIRS)! 🌟 Dive into the latest issue of TIRS for groundbreaking original research, insightful reviews, and more! 📚🔍 Don't miss out on these key articles driving forward innovation and regulatory science! #ClinicalResearch #DrugDevelopment #Pharmaceuticals #RegulatoryScience #Oncology #Biostatistics #ClinicalTrials #OpenAccess #MedicalDevices #PatientEngagement #Pharma #HealthResearch #GlobalHealth #MedicalInnovation #DecentralizedTrials
Therapeutic Innovation & Regulatory Science | Journal collections
link.springer.com
-
DIA转发了
Certified Meeting Professional (CMP) & Digital Event Strategist (DES) | Expert Planner and Problem Solver | Creating Memorable and Impactful Events
✳ DIA 2025 - Call for Abstracts Now Open!✳ Here is your chance to be part of the conversation in Washington, DC. (June 15-19, 2025) Our Track Chairs have highlighted priority topics within their educational tracks to provide direction on the content they would like to receive via the Call for Abstracts. You can submit abstracts addressing priority topics and/or topics relevant to the DIA 2025 track descriptions. Open Date: August 8, 2024 Close Date: September 12, 2024 We will accept abstracts for sessions, forums, workshops, and short courses. For more information, or to submit, please visit: https://lnkd.in/ebtzUP22 Questions? Contact DIA at AnnualMeetingProgram@DIAglobal.org #DIA2025 #callforabstracts #clinicalsafety #pharmacovigilance #clinicaltrials #clinicaloperations #Data #AI #medicalaffairs #medicalwriting #PersonalizedMedicine #CombinationProducts #diagnostics #projectmanagement #Regulatory #RegulatoryCMC #statistics #datascience #professionaldevelopment
-
-
DIA转发了
"Users of #RWD analysis reported that RWD add context to and increase confidence in signal assessments, and that RWD analyses reduce time to decision-making when done rapidly and properly. Rapid RWD analyses can bring awareness to potential #safety issues sooner which, in turn, promotes patient safety and public health. Routine users indicated that most signal assessments could benefit from rapid RWD analysis while non-routine users showed a greater unmet need for rapid analysis.” #realworlddata #data #regulatory #rwd #realworldevidence #outcomes #patientoutcomes #realworldoutcomes #pharma #innovation #dia #pharmacovigilance #ehr #claims DIA #ema #fda #ispe2024 #pharmacoepidemiology International Society for Pharmacoepidemiology
-
We are delighted to present the outcomes of the DIA Europe 2024 Pre-Conference Workshop on "Reliance for Post-Approval Changes: How do we move from Exceptional to Routine Use?" and the DIA Global Forum Article on "Making Global Reliance a Reality for Post-Approval Changes of Medicines and Vaccines". As the regulatory landscape evolves, the need for global collaboration has never been more critical. This workshop brought together global regulators and industry leaders to discuss how reliance models can be expanded to streamline post-approval changes (PACs) across markets. The outcomes highlight key steps toward making reliance for PAC a routine practice, reducing delays, and ensuring timely access to medicines and vaccines worldwide. ◾ Download the outcomes: https://bit.ly/4cKzpzm. ◾ Read the Global Forum article: https://bit.ly/3X8Nzok. As we look ahead, we invite you to join us at the DIA Europe 2025 to continue these critical discussions. Let’s work together to foster collaboration, drive innovation, and create a sustainable future for global healthcare. Register by 14 November to benefit from the early bird rate. ◾ Registration link: https://bit.ly/4aN1NA1. Chimwemwe Chamdimba, Biljana Tubić, Elkiana Rama, Nélio Cézar De Aquino, Jiaqi Lu, Tao Wang, Xiangyu Wang, Sabina Uzeirbegovic, Hamada Gamal, Martin Harvey Allchurch, Reem Al-Naimat, Ahmed Hussein Babiker, Bandar Alhammad, Marko Eric, Mladen Bogdanovic, F. Handan Öztunca, Musa Durak, Marie Valentin, Samvel Azatyan, Gugu N Mahlangu, Alison Bond, Lucia D'Apote, Mark Pellett, Priti Shah, Michael Cunha, Vera Lucie Wardhana, Hugo Ta, Michelle Czajkowski, Andrew Deavin, Dave Rush, Sérgio Cavalheiro Filho, Ginny Beakes-Read, Greg Jordinson, Chloé Garay, Sonia Cappellini, isabelle colmagne-poulard, Wan Li Liao, PhD, Angelika Joos, Mic McGoldrick, Inas Hujeiri Chehimi, Jacob Larsen, Aine Kane, Anjana Patel, Yameng (Melly) Lin, Susanne A., Corinne CHABASSOL, Lyne Le Palaire, Anna Czwarno, Magda Bujar, Tamei Elliott, Sara Torgal #DIAEurope2025 #LifeSciences #Sustainability #Reliance #Collaboration
-